ExodusPoint Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

ExodusPoint Capital Management’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Sell	20,250 -10,070	-33%	-$643K	0.01%	996
2026 Q1	$2.13M	Sell	30,320 -21,167	-41%	-$1.48M	0.02%	762
2025 Q4	$4.22M	Buy	+51,487	New	+$3.84M	0.03%	540
2024 Q4	–	Sell	-883,043	Closed	-$29M	–	2046
2024 Q3	$29M	Buy	883,043 +212,584	+32%	+$5.98M	0.18%	96
2024 Q2	$18.2M	Buy	670,459 +454,501	+210%	+$15.3M	0.12%	145
2024 Q1	$7.85M	Sell	215,958 -16,942	-7%	-$498K	0.06%	251
2023 Q4	$4.72M	Sell	232,900 -165,741	-42%	-$2.77M	0.03%	357
2023 Q3	$7.08M	Buy	398,641 +203,820	+105%	+$3.61M	0.07%	296
2023 Q2	$3.52M	Buy	+194,821	New	+$3.1M	0.03%	580

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ExodusPoint Capital Management's TARS Position: Q2 2026 in Review

ExodusPoint Capital Management reduced its Tarsus Pharmaceuticals (TARS) stake by 33% in Q2 2026, selling an estimated $643K and leaving 20,250 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #996.

ExodusPoint Capital Management first reported a position in TARS in Q2 2023 and has held it in 9 quarters since. The position peaked at $29M in Q3 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

ExodusPoint Capital Management held 20,250 shares of Tarsus Pharmaceuticals worth $1.27M as of Q2 2026.
ExodusPoint Capital Management sold 10,070 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $643K.
Tarsus Pharmaceuticals made up 0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #996 holding.
ExodusPoint Capital Management first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
ExodusPoint Capital Management's Tarsus Pharmaceuticals position peaked at $29M in Q3 2024.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.